TRIM25: Tripartite Motif Containing 25

E3 ubiquitin-protein ligase involved in innate immunity and cancer

Gene Information Card

Symbol TRIM25
Full Name Tripartite Motif Containing 25
Gene Type Protein coding
Chromosomal Location 17q22
NCBI Gene ID 7706 ncbi.nlm.nih.gov/gene/7706
Ensembl ID ENSG00000121060
UniProt ID Q14258
OMIM ID 604357
HGNC ID 16271
Aliases EFP, ZNF147, RNF147, UIP28

Description

TRIM25 (tripartite motif containing 25) encodes a member of the tripartite motif (TRIM) family. The protein functions as an E3 ubiquitin-protein ligase, catalyzing the ubiquitination of target proteins. It is best known for its role in innate antiviral immunity by mediating the ubiquitination of the cytosolic RNA sensor RIG-I (DDX58), which is essential for RIG-I activation and downstream interferon signaling. TRIM25 also participates in estrogen receptor signaling and has been implicated in various cancers, including breast cancer, where it can act as an oncogene or tumor suppressor depending on context.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer TRIM25 overexpression enhances estrogen receptor alpha (ERα) transcriptional activity and promotes cell proliferation; also linked to tamoxifen resistance. PMID: 15601869, PMID: 21502522
Viral Infections (Influenza, Dengue) TRIM25-mediated RIG-I ubiquitination is critical for interferon induction; viruses such as influenza A and dengue virus target TRIM25 to evade immune response. PMID: 17981124, PMID: 25146922
Colorectal Cancer TRIM25 is upregulated and associated with poor prognosis; promotes Wnt/β-catenin signaling. PMID: 28411371
Ovarian Cancer TRIM25 expression correlates with tumor grade and metastasis; may regulate p53 stability. PMID: 25944712

Expression Profile

Tissue Expression
Tissue nTPM level
Breast 12.3 Medium
Lung 8.7 Medium
Liver 6.2 Low
Kidney 5.1 Low
Testis 15.8 High
Lymph node 9.4 Medium
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 14.2 ER-positive; high TRIM25 expression
A549 (lung cancer) 10.1 Moderate expression
HepG2 (liver cancer) 7.3 Low expression
HEK293 (embryonic kidney) 11.5 Common model for TRIM25 studies
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1015C>T (p.Arg339Trp) Missense <0.01% Unknown; rare variant in population databases
c.1246G>A (p.Glu416Lys) Missense <0.01% Reported in breast cancer; functional impact unclear
c.1630_1631insA (p.Thr544Asnfs*2) Frameshift <0.01% Predicted loss of function; observed in colorectal cancer
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that truncate the RING or coiled-coil domains impair E3 ligase activity and RIG-I ubiquitination.

Gain of Function (GOF)

Missense mutations in the SPRY domain may enhance substrate binding or alter specificity, but evidence is limited.

Dominant Negative (DN)

Mutations in the RING domain that disrupt zinc coordination can produce dominant-negative effects by sequestering substrates or blocking wild-type TRIM25.

Gene Ontology (GO)

• GO:0004842 - ubiquitin-protein transferase activity • GO:0005515 - protein binding
• GO:0008270 - zinc ion binding • GO:0016567 - protein ubiquitination
• GO:0032481 - positive regulation of type I interferon production • GO:0045087 - innate immune response
• GO:0061630 - ubiquitin protein ligase activity

Pathways

RIG-I/MDA5 mediated induction of interferon-alpha/beta (Reactome: R-HSA-936440)
Antiviral mechanism by IFN-stimulated genes (Reactome: R-HSA-1169410)
Estrogen-dependent gene expression (Reactome: R-HSA-8939211)

Protein Summary

TRIM25 is a 72 kDa protein containing an N-terminal RING finger domain, two B-box domains, a coiled-coil region, and a C-terminal SPRY domain. The RING domain confers E3 ubiquitin ligase activity, while the SPRY domain mediates substrate recognition. TRIM25 is primarily cytoplasmic and undergoes self-ubiquitination. Its best-characterized substrate is RIG-I, where TRIM25 attaches K63-linked polyubiquitin chains to the CARD domains, enabling RIG-I to activate MAVS and trigger interferon production. TRIM25 also ubiquitinates other targets including p53, ZAP, and ERα, linking it to both antiviral defense and cancer biology.

Related Products

Product name Cat.No. Species Gene ID
TRIM25 Knockout HEK293 Cell Line EDJ-KQ604 Human 7706 Details Get a Quote
TRIM25 Knockout A-549 Cell Line EDC09755 Human 7706 Details Get a Quote
TRIM25 Knockout HCT 116 Cell Line EDJ-KQ19056 Human 7706 Details Get a Quote
TRIM25 Knockout HeLa Cell Line EDJ-KQ18315 Human 7706 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: